| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A decade of data: Adolescent vaccination in the vaccine safety datalink, 2007 through 2016
|
Irving, Stephanie A.
|
|
|
40 |
9 |
p. 1246-1252
|
artikel
|
| 2 |
An AAV vaccine targeting the RBD of the SARS-CoV-2 S protein induces effective neutralizing antibody titers in mice and canines
|
Liu, Fei
|
|
|
40 |
9 |
p. 1208-1212
|
artikel
|
| 3 |
A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system
|
Gorse, Geoffrey J.
|
|
|
40 |
9 |
p. 1271-1281
|
artikel
|
| 4 |
A scalable, integrated downstream process for production of a recombinant measles virus-vectored vaccine
|
Steppert, Petra
|
|
|
40 |
9 |
p. 1323-1333
|
artikel
|
| 5 |
B-cell cytopenia and time to last B-cell-depleting therapy predict response to SARS-COV-2 vaccines in patients with lymphoproliferative disorders
|
Tanguay, Mégane
|
|
|
40 |
9 |
p. 1203-1207
|
artikel
|
| 6 |
Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix® or Gardasil® vaccine
|
Panwar, Kavita
|
|
|
40 |
9 |
p. 1198-1202
|
artikel
|
| 7 |
Conditionality of COVID-19 vaccine acceptance in European countries
|
Heyerdahl, Leonardo W.
|
|
|
40 |
9 |
p. 1191-1197
|
artikel
|
| 8 |
Corrigendum to ‘Meningococcal vaccination in patients with newly diagnosed asplenia in the United States’ [Vaccine 39 (2021) 272–281]
|
Ghaswalla, Parinaz K.
|
|
|
40 |
9 |
p. 1383
|
artikel
|
| 9 |
COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population
|
Shaw, Jana
|
|
|
40 |
9 |
p. 1231-1237
|
artikel
|
| 10 |
Critical success factors for conducting human challenge trials for vaccine development in low- and middle-income countries
|
Msusa, Keiko Pempho
|
|
|
40 |
9 |
p. 1261-1270
|
artikel
|
| 11 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
9 |
p. IFC
|
artikel
|
| 12 |
Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project
|
Paget, John
|
|
|
40 |
9 |
p. 1361-1369
|
artikel
|
| 13 |
Health and economic impact of seasonal influenza mass vaccination strategies in European settings: A mathematical modelling and cost-effectiveness analysis
|
Sandmann, Frank G.
|
|
|
40 |
9 |
p. 1306-1315
|
artikel
|
| 14 |
Hepatitis B vaccine co-administration influences the heterologous effects of neonatal BCG vaccination in a sex-differential manner
|
Pittet, Laure F.
|
|
|
40 |
9 |
p. 1334-1341
|
artikel
|
| 15 |
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation
|
McGoldrick, Mic
|
|
|
40 |
9 |
p. 1223-1230
|
artikel
|
| 16 |
How to accelerate the supply of vaccines to all populations worldwide? Part I: Initial industry lessons learned and practical overarching proposals leveraging the COVID-19 situation
|
McGoldrick, Mic
|
|
|
40 |
9 |
p. 1215-1222
|
artikel
|
| 17 |
Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors
|
Takeshita, Kenichi
|
|
|
40 |
9 |
p. 1238-1245
|
artikel
|
| 18 |
Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China
|
He, Qing
|
|
|
40 |
9 |
p. 1370-1375
|
artikel
|
| 19 |
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE)
|
Simon, Jakub K.
|
|
|
40 |
9 |
p. 1342-1351
|
artikel
|
| 20 |
Measles susceptibility in maternal-infant dyads—Bamako, Mali
|
Dixon, Meredith G.
|
|
|
40 |
9 |
p. 1316-1322
|
artikel
|
| 21 |
Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model
|
Kalnin, Kirill V.
|
|
|
40 |
9 |
p. 1289-1298
|
artikel
|
| 22 |
Pertussis burden and acellular pertussis vaccine effectiveness in high risk children
|
Sheridan, Sarah
|
|
|
40 |
9 |
p. 1376-1382
|
artikel
|
| 23 |
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
|
Janssen, Yester F.
|
|
|
40 |
9 |
p. 1253-1260
|
artikel
|
| 24 |
Reducing the rates of household transmission: The impact of COVID-19 vaccination in healthcare workers with a known household exposure
|
Passaretti, Catherine L.
|
|
|
40 |
9 |
p. 1213-1214
|
artikel
|
| 25 |
Spatial patterns of HPV and Tdap vaccine dose administration and the association of health department clinic access in Georgia counties
|
White, Ashley A.
|
|
|
40 |
9 |
p. 1352-1360
|
artikel
|
| 26 |
The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study
|
Ding, Hanyue
|
|
|
40 |
9 |
p. 1282-1288
|
artikel
|
| 27 |
Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial
|
Kantele, Anu
|
|
|
40 |
9 |
p. 1299-1305
|
artikel
|
Tijdschrift beschrijving